3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Polycystic Ovary Syndrome
1
Insulin Resistance
1
Interventions
Metformin
41
Clomiphene
17
Letrozole
6
Menotropins
5
Folic Acid
5
drospirenone and ethinyl estradiol combination
4
Liraglutide
4
Chorionic Gonadotropin
4
cetrorelix
3
Triptorelin Pamoate
3
Progesterone
3
Pioglitazone
3
Leuprolide
3
Inositol
3
Exenatide
3
Ethinyl Estradiol
3
Estradiol
3
Vitamins
2
Sperm Injections, Intracytoplasmic
2
Sitagliptin Phosphate
2
Simvastatin
2
Gonadotropins
2
Glycoprotein Hormones, alpha Subunit
2
Exercise
2
Escitalopram
2
Cyproterone acetate, ethinyl estradiol drug combination
2
Contraceptives, Oral
2
Cholecalciferol
2
Carnitine
2
Canagliflozin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Polycystic Ovary Syndrome
×
Sodium-Glucose Transporter 2 Inhibitors
×
Clear all
NCT04700839
2022-09-10
PCOS
Shanghai 10th People's Hospital
Phase 4
Completed
68 enrolled